Benjamin F. Edwards & Company, Inc. Gilead Sciences, Inc. Transaction History

Benjamin F. Edwards & Company, Inc.

$5.51 Billion
Q1 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 334,770 shares of GILD stock, worth $22.3 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

334,770

Previous 321,621 4.09%

Holding current value

$22.3 Million

Previous $26.1 Million 5.88%

% of portfolio

0.45%

Previous 0.52%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$71.58 - $87.29 $941,205 - $1.15 Million	13,149 Added 4.09%	334,770 $24.5 Million
Q4 2023 Feb 06, 2024	BUY	$73.27 - $83.09 $19.3 Million - $21.9 Million	263,264 Added 451.13%	321,621 $26.1 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $615,994 - $672,061	-8,331 Reduced 12.49%	58,357 $4.37 Million
Q2 2023 Aug 15, 2023	BUY	$76.01 - $86.7 $2.22 Million - $2.54 Million	29,266 Added 78.21%	66,688 $5.14 Million
Q1 2023 Apr 27, 2023	SELL	$77.31 - $88.08 $461,927 - $526,278	-5,975 Reduced 13.77%	37,422 $3.11 Million

Q4 2022 Feb 07, 2023	BUY	$62.32 - $89.47 $28,604 - $41,066	459 Added 1.07%	43,397 $3.73 Million
Q3 2022 Oct 28, 2022	BUY	$59.54 - $68.01 $84,963 - $97,050	1,427 Added 3.44%	42,938 $2.65 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $307,359 - $346,178	5,325 Added 14.72%	41,511 $2.57 Million
Q1 2022 May 04, 2022	BUY	$57.92 - $72.58 $324,236 - $406,302	5,598 Added 18.3%	36,186 $2.15 Million
Q4 2021 Feb 07, 2022	BUY	$64.88 - $73.64 $24,265 - $27,541	374 Added 1.24%	30,588 $2.22 Million
Q3 2021 Nov 02, 2021	BUY	$67.69 - $73.03 $95,104 - $102,607	1,405 Added 4.88%	30,214 $2.11 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $11,615 - $12,691	183 Added 0.64%	28,809 $1.98 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $122,880 - $140,206	-2,048 Reduced 6.68%	28,626 $1.85 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $72,681 - $82,817	-1,283 Reduced 4.01%	30,674 $1.79 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $53,840 - $67,695	867 Added 2.79%	31,957 $2.02 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $38,991 - $45,276	-539 Reduced 1.7%	31,090 $2.39 Million
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $216,136 - $276,839	-3,451 Reduced 9.84%	31,629 $2.37 Million
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $49,234 - $54,156	799 Added 2.33%	35,080 $2.28 Million
Q3 2019 Nov 05, 2019	BUY	$62.51 - $69.0 $136,646 - $150,834	2,186 Added 6.81%	34,281 $2.17 Million
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $200,458 - $224,791	3,240 Added 11.23%	32,095 $2.17 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $26,262 - $29,421	-420 Reduced 1.43%	28,855 $1.88 Million
Q4 2018 Jan 31, 2019	BUY	$60.54 - $79.0 $62,840 - $82,002	1,038 Added 3.68%	29,275 $1.83 Million
Q3 2018 Oct 29, 2018	SELL	$71.28 - $78.92 $68,428 - $75,763	-960 Reduced 3.29%	28,237 $2.18 Million
Q2 2018 Jul 19, 2018	SELL	$64.88 - $75.68 $83,435 - $97,324	-1,286 Reduced 4.22%	29,197 $2.07 Million
Q1 2018 Apr 17, 2018	BUY	$72.84 - $88.8 $251,516 - $306,626	3,453 Added 12.77%	30,483 $2.3 Million
Q4 2017 Jan 17, 2018	SELL	$71.15 - $83.52 $43,188 - $50,696	-607 Reduced 2.2%	27,030 $1.94 Million
Q3 2017 Oct 24, 2017	BUY	$72.11 - $85.47 $1.99 Million - $2.36 Million	27,637	27,637 $2.24 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Gilead Sciences, Inc. Transaction History